Sales Support:
sales@worldwidemarketreports.com
U.S.:+1 415 871 0703
U.K.:+44-203-289-4040
JAPAN: +81-50-5539-1737
INDIA:+91-848-285-0837
Menu Icon Close Icon
We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.

Global Hepatitis B Virus [HBV] Treatment Market - Analysis By Type (Therapeutics, Vaccine), By End User (Male, Female) - By Region, By Country: Opportunities and Forecast (2017-2022) - By Region (N. America, Europe, APAC, ROW), By Country (US, Canada, UK, Germany, France, China, India, Japan)

Executive Summary

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Hepatitis B Treatment Market by Type (Therapeutics and Vaccines), By End-User (Male and Female) for the regions (North America, Europe, Asia—Pacific and ROW) and By Country (U.S., Canada, U.K., Germany, France, China, India, Japan).

Over the recent years, the global Hepatitis B Treatment industry has been driven by the increasing number of patients diagnosed with Chronic Hepatitis B which results in severe complications, rising awareness about the consequences of viral infection, rigorous efforts to eliminate the viral infection, improving surveillance and diagnostic facilities, significant number of drugs in pipeline with better efficacy coupled with emerging vaccines with lower dosage and better effectiveness. Globally, the growth in Hepatitis B Treatment market is driven by backed by growing middle class population group demanding better drugs to improve lifestyle.

According to Azoth Analytics research report "Global Hepatitis B Virus [HBV] Treatment Market - Analysis By Type (Therapeutics, Vaccine), By End User (Male, Female) - By Region, By Country: Opportunities and Forecast (2017-2022) - By Region (N. America, Europe, APAC, ROW), By Country (US, Canada, UK, Germany, France, China, India, Japan)", global market is projected to display a growth represented by a CAGR of 5.30% by value during 2017 - 2022, chiefly driven by increase in healthcare spending and improving access to diagnosis for Chronic Hepatitis B, increasing risk of severe complications due to Hepatitis B virus.

Among the type of treatment, therapeutics accounts for the major market share and anticipated to witness significant growth rate during the forecast period. Among the regions, Asia Pacific is predicted to advance at the highest rate, mainly driven by large population suffering with chronic Hepatitis B virus with unfulfilled need, improving access to healthcare, changing lifestyle and expanding middle class income group.

The report titled, "Global Hepatitis B Virus [HBV] Treatment Market - Analysis By Type (Therapeutics, Vaccine), By End User (Male, Female) - By Region, By Country: Opportunities and Forecast (2017-2022) - By Region (N. America, Europe, APAC, ROW), By Country (US, Canada, UK, Germany, France, China, India, Japan)" has covered and analysed the potential of Hepatitis B Treatment Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global Hepatitis B Treatment market. Additionally, the report also highlights market entry strategies for various companies across the globe.


Scope of the Report

Global Market (Actual Period: 2012-2016, Forecast Period: 2017-2022)
• Global Hepatitis B Treatment Market
• Analysis By Type (Therapeutics and Vaccines)
• Analysis By End-User (Male and Female)

Regional Markets - North America, Europe, APAC, ROW (Actual Period: 2012-2016, Forecast Period: 2017-2022)
• By Type (Therapeutics and Vaccines)
• By End-User (Male and Female)

Country Analysis - United States, Canada, United Kingdom, Germany, France, China, India, Japan (Actual Period: 2012-2016, Forecast Period: 2017-2022)
• By Type (Therapeutics and Vaccines)
• By End-User (Male and Female)

Other Report Highlights
• Market Dynamics - Trends, Drivers, Challenges, Policy and Regulation
• Company Analysis - Merck and Co; Gilead Sciences; Novartis AG; GlaxoSmithKline, plc; Hoffmann- La Roche; Bristol-Myers Squibb

Customization of the Report
The report could be customized according to the client's specific research requirements. No additional cost will be required to pay for limited additional research. 



Table of Contents

1. Research Methodology

2. Executive Summary

3. Strategic Recommendations

4. Hepatitis B Treatment Market: Product Outlook

5. Global Hepatitis B Treatment Market: Growth and Forecast
5.1. Global Hepatitis B Treatment Market, By Value (2012-2016)
5.2. Global Hepatitis B Treatment Market, By Value (2017-2022)
5.3. Global Hepatitis B Treatment Market - By Type, By Value
5.3.1. Global Hepatitis B Treatment Market, By Value, % (2016)
5.3.2. Global Hepatitis B Treatment Market, By Value, % (Forecast 2022F)
5.4. Global Hepatitis B Treatment Market, By Type, By Value (2012-2022)
5.4.1. Therapeutics, By Value (2012-2022)
5.4.2. Vaccines, By Value (2012-2022)
5.5. Global Hepatitis B Treatment Market, By End-User, By Value (2012-2022)
5.5.1. Male, By Value (2012-2022)
5.5.2. Female, By Value (2012-2022)

6. North America Hepatitis B Treatment Market: Growth and Forecast
6.1. North America Hepatitis B Treatment Market, By Value (2012-2016)
6.2. North America Hepatitis B Treatment Market, By Value (2017-2022)
6.3. North America Hepatitis B Treatment Market - By Type, By Value
6.3.1. North America Hepatitis B Treatment Market, By Value, % (2016)
6.3.2. North America Hepatitis B Treatment Market, By Value, % (Forecast 2022F)
6.4. North America Hepatitis B Treatment Market, By Type, By Value (2012-2022)
6.4.1. Therapeutics, By Value (2012-2022)
6.4.2. Vaccines, By Value (2012-2022)
6.5. North America Hepatitis B Treatment Market, By End-User, By Value (2012-2022)
6.5.1. Male, By Value (2012-2022)
6.5.2. Female, By Value (2012-2022)

6.6. North America Hepatitis B Treatment Market: Country Analysis (U.S., Canada)
6.6.1. North America Hepatitis B Treatment Market, Country Share, 2016 (% of Total)
6.6.2. North America Hepatitis B Treatment Market, Country Share, 2022 (% of Total)

6.7. U.S. Hepatitis B Treatment Market: Growth and Forecast
6.7.1. U.S. Hepatitis B Treatment Market, By Value (2012-2016)
6.7.2. U.S. Hepatitis B Treatment Market, By Value (2017-2022)
6.8. U.S. Hepatitis B Treatment Market - By Type, By Value
6.8.1. Therapeutics, By Value (2012-2022)
6.8.2. Vaccines, By Value (2012-2022)
6.9. U.S. Hepatitis B Treatment Market - By End-User, By Value
6.9.1. Male, By Value (2012-2022)
6.9.2. Female, By Value (2012-2022)

6.10. Canada Hepatitis B Treatment Market: Growth and Forecast
6.10.1. Canada Hepatitis B Treatment Market, By Value (2012-2016)
6.10.2. Canada Hepatitis B Treatment Market, By Value (2017-2022)
6.11. Canada Hepatitis B Treatment Market - By Type, By Value
6.11.1. Therapeutics, By Value (2012-2022)
6.11.2. Vaccines, By Value (2012-2022)
6.12. Canada Hepatitis B Treatment Market - By End-User, By Value
6.12.1. Male, By Value (2012-2022)
6.12.2. Female, By Value (2012-2022)

7. Europe Hepatitis B Treatment Market: Growth and Forecast
7.1. Europe Hepatitis B Treatment Market, By Value (2012-2016)
7.2. Europe Hepatitis B Treatment Market, By Value (2017-2022)
7.3. Europe Hepatitis B Treatment Market - By Type, By Value
7.3.1. Europe Hepatitis B Treatment Market, By Value, % (2016)
7.3.2. Europe Hepatitis B Treatment Market, By Value, % (Forecast 2022F)
7.4. Europe Hepatitis B Treatment Market, By Type, By Value (2012-2022)
7.4.1. Therapeutics, By Value (2012-2022)
7.4.2. Vaccines, By Value (2012-2022)
7.5. Europe Hepatitis B Treatment Market, By End-User, By Value (2012-2022)
7.5.1. Male, By Value (2012-2022)
7.5.2. Female, By Value (2012-2022)

7.6. Euope Hepatitis B Treatment Market: Country Analysis (U.K., Germany, France)
7.6.1. Europe Hepatitis B Treatment Market, Country Share, 2016 (% of Total)
7.6.2. Europe Hepatitis B Treatment Market, Country Share, 2022 (% of Total)

7.7. U.K. Hepatitis B Treatment Market: Growth and Forecast
7.7.1. U.K. Hepatitis B Treatment Market, By Value (2012-2016)
7.7.2. U.K. Hepatitis B Treatment Market, By Value (2017-2022)
7.8. U.K. Hepatitis B Treatment Market - By Type, By Value
7.8.1. Therapeutics, By Value (2012-2022)
7.8.2. Vaccines, By Value (2012-2022)
7.9. U.K. Hepatitis B Treatment Market - By End-User, By Value
7.9.1. Male, By Value (2012-2022)
7.9.2. Female, By Value (2012-2022)

7.10. Germany Hepatitis B Treatment Market: Growth and Forecast
7.10.1. Germany Hepatitis B Treatment Market, By Value (2012-2016)
7.10.2. Germany Hepatitis B Treatment Market, By Value (2017-2022)
7.11. Germany Hepatitis B Treatment Market - By Type, By Value
7.11.1. Therapeutics, By Value (2012-2022)
7.11.2. Vaccines, By Value (2012-2022)
7.12. Germany Hepatitis B Treatment Market - By End-User, By Value
7.12.1. Male, By Value (2012-2022)
7.12.2. Female, By Value (2012-2022)

7.13. France Hepatitis B Treatment Market: Growth and Forecast
7.13.1. France Hepatitis B Treatment Market, By Value (2012-2016)
7.13.2. France Hepatitis B Treatment Market, By Value (2017-2022)
7.14. France Hepatitis B Treatment Market - By Type, By Value
7.14.1. Therapeutics, By Value (2012-2022)
7.14.2. Vaccines, By Value (2012-2022)
7.15. France Hepatitis B Treatment Market - By End-User, By Value
7.15.1. Male, By Value (2012-2022)
7.15.2. Female, By Value (2012-2022)

8. Asia-Pacific Hepatitis B Treatment Market: Growth and Forecast
8.1. Asia-Pacific Hepatitis B Treatment Market, By Value (2012-2016)
8.2. Asia-Pacific Hepatitis B Treatment Market, By Value (2017-2022)
8.3. Asia-Pacific Hepatitis B Treatment Market - By Type, By Value
8.3.1. Asia-Pacific Hepatitis B Treatment Market, By Value, % (2016)
8.3.2. Asia-Pacific Hepatitis B Treatment Market, By Value, % (Forecast 2022F)
8.4. Asia-Pacific Hepatitis B Treatment Market, By Type, By Value (2012-2022)
8.4.1. Therapeutics, By Value (2012-2022)
8.4.2. Vaccines, By Value (2012-2022)
8.5. Asia-Pacific Hepatitis B Treatment Market, By End-User, By Value (2012-2022)
8.5.1. Male, By Value (2012-2022)
8.5.2. Female, By Value (2012-2022)

8.6. Asia-Pacific Hepatitis B Treatment Market: Country Analysis (Japan, China, India)
8.6.1. Asia-Pacific Hepatitis B Treatment Market, Country Share, 2016 (% of Total)
8.6.2. Asia-Pacific Hepatitis B Treatment Market, Country Share, 2022 (% of Total)

8.7. Japan Hepatitis B Treatment Market: Growth and Forecast
8.7.1. Japan Hepatitis B Treatment Market, By Value (2012-2016)
8.7.2. Japan Hepatitis B Treatment Market, By Value (2017-2022)
8.8. Japan Hepatitis B Treatment Market - By Type, By Value
8.8.1. Therapeutics, By Value (2012-2022)
8.8.2. Vaccines, By Value (2012-2022)
8.9. Japan Hepatitis B Treatment Market - By End-User, By Value
8.9.1. Male, By Value (2012-2022)
8.9.2. Female, By Value (2012-2022)

8.10. China Hepatitis B Treatment Market: Growth and Forecast
8.10.1. China Hepatitis B Treatment Market, By Value (2012-2016)
8.10.2. China Hepatitis B Treatment Market, By Value (2017-2022)
8.11. China Hepatitis B Treatment Market - By Type, By Value
8.11.1. Therapeutics, By Value (2012-2022)
8.11.2. Vaccines, By Value (2012-2022)
8.12. China Hepatitis B Treatment Market - By End-User, By Value
8.12.1. Male, By Value (2012-2022)
8.12.2. Female, By Value (2012-2022)

8.13. India Hepatitis B Treatment Market: Growth and Forecast
8.13.1. India Hepatitis B Treatment Market, By Value (2012-2016)
8.13.2. India Hepatitis B Treatment Market, By Value (2017-2022)
8.14. India Hepatitis B Treatment Market - By Type, By Value
8.14.1. Therapeutics, By Value (2012-2022)
8.14.2. Vaccines, By Value (2012-2022)
8.15. India Hepatitis B Treatment Market - By End-User, By Value
8.15.1. Male, By Value (2012-2022)
8.15.2. Female, By Value (2012-2022)

9. ROW Hepatitis B Treatment Market: Growth and Forecast
9.1. ROW Hepatitis B Treatment Market, By Value (2012-2016)
9.2. ROW Hepatitis B Treatment Market, By Value (2017-2022)

10. Market Dynamics
10.1. Increasing prevalence of Liver diseases due to Hepatitis B
10.2. Increasing awareness about the Hepatitis B & HBV
10.3. Rising healthcare expenditure worldwide

11. Market Restraints

12. SWOT Analysis - Hepatitis B Treatment Market

13. Porter's Five Forces Analysis

14. Policy and Regulations

15. Global Hepatitis B Drugs Pipeline

16. Global Hepatitis B Treatment Market - Competitive Landscape

17. Company Profiles
17.1. Merck and Co
17.2. Gilead Sciences
17.3. Novartis AG
17.4. GlaxoSmithKline, plc
17.5. F.Hoffmann- La Roche
17.6. Bristol-Myers Squibb
17.7. AbbVie Inc

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by:
  • Product Types
  • Drug Class
  • Indication
  • Applications
  • Services Types
  • End-users
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers
  • Restraints
  • Pipeline Analysis
  • Incidence Rate
  • Epidemiology Analysis
  • Prevalence rate
  • Regulatory scenario
  • Industry trend
  • Pestle Analysis
  • Porter’s Analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.

Related Reports

Global Systemic Aspergillosis And Systemic Candidiasis Market (2024 Edition): Analysis By Type ...
View More
Solar Water Treatment System Market Size And Share Analysis - Growth Trends And Forecasts (2024...
View More
Zero Liquid Discharge (ZLD) Brine Treatment Market Size And Share Analysis - Growth Trends And ...
View More
Global Medical Tourism Market (2024 Edition): Analysis By Service Provider (Public, And Private...
View More
Global Fertility Services Market (2024 Edition): Analysis By Gender (Male, Female), Treatment T...
View More

Trusted Clients
A-T- Kearney.png
AbbVie.png
Agrinos.png
AIF-Metrics.png
Akzo-Nobel.jpg
Alfi-GMBH.png
Allergan.png
Almasra-Scientific-Bureau.jpg
ALPMA.jpg
Americana-Foods.png
ANP.png
Aptar-Group-Germany.jpg
asahi-kasei.png
ATC.png
atlas-servair.jpg
ATOS.png
Avalon.png
biofishency.png
biomx.png
borealisgroup.png
Cape-Peninsula.png
CBRE.png
Cennerv-Pharma.jpg
Clearponds.png
Compass-Group.png
Cortag-Industria.png
Covis-Pharma.jpg
DAIMLER-AG.jpg
Edipresse-Media.jpg
Epson.png
Evonik-Industries-AG.png
ExcelSource.png
Fingo.png
Firstkind.png
FLM-Foodingredients.png
Freudenberg.png
Fueltrax.jpg
Fugro-International.png
Fuji-Films.png
Funky-Sound-Studio.png
GALTWAY.png
Gartner.png
GBSC.png
Global-Information.jpg
Hanwha-Total-Petrochemical.png
Hebrew.png
Horiba-Mira.png
Hunter-and-Co-Investments.png
Hyosung.png
Hyssopus-Organics.jpg
IBSA.png
Ideagen.png
IMS.png
InSinkErator.png
Intas-Pharma.png
IntelMed-Sarl.png
Interdiligence-Consulting.png
Israel-Shopyards.png
Johnsons-Controls.png
kakaxi.jpg
KORDSA.png
kotra.png
KPMG.png
lantmannen.png
LEK.png
LG.jpg
Makuri-Technology.jpg
Mallinckrodt.png
Mappo.png
Maprimed.jpg
mcns.jpg
MED-EL.png
Mehr-Azin-Pouya-Sahand.png
Molkerei-Ammerland-eG.png
Monty-Holding.jpg
mpmaterials.png
Mundipharma.png
Nasco.png
Nitto.png
Nouryon.png
NOXTAK.png
Oskars.png
Paidotribo.png
Parnell-Pharmaceuticals.png
Podravka.png
ppg.png
Privi.png
Publicis Groupe.png
Qvetech.jpg
R3P.jpg
Samsung.png
Sapient.png
SEW-EURODRIVE.png
Shivananda.jpg
Silver-Clouds.png
SMIT.jpg
SOLVIAS.png
Spectrum.png
SR-Instruments-Oy.png
Star-Seed.png
Stryker -ENT.png
Synjenta.png
Terumo-Corp.png
TherOzone.png
Toshiba.png
TT-Electronics.png
umbc.edu.png
Vard.jpg
Vital-Xense.png
Walraven.png
Wlgore.png
Woodmac.png
WWF-UK.png
ZENOAQ.png
Zuellig-Pharma.png
Contact us

sales@worldwidemarketreports.com

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports, 403, 4th Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

phoneiconU.S.:+1 415 871 0703

phoneiconUK :+44-203-289-4040

phoneiconJapan :+81-50-5539-1737

phoneiconIndia :+91-848-285-0837

Menu
Quick Links
Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).


Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2024 Worldwide Market Reports. All Rights Reserved